Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
The field of oncology is continuously evolving, driven by advancements in molecular biology and pharmaceutical chemistry. NINGBO INNO PHARMCHEM CO.,LTD. actively participates in this progress by supplying critical pharmaceutical ingredients, such as Lapatinib Ditosylate, a vital drug in the treatment of advanced cancers.
Lapatinib Ditosylate is a potent oral medication that operates as a dual tyrosine kinase inhibitor, targeting both EGFR and HER2. These receptors are frequently implicated in the growth and spread of various cancers, particularly HER2-positive breast cancer. By inhibiting these key signaling pathways, Lapatinib Ditosylate effectively disrupts the mechanisms that cancer cells rely on for survival and proliferation. The detailed Lapatinib Ditosylate mechanism of action involves binding to the intracellular ATP-binding pocket of these kinases, thereby preventing downstream signaling.
The clinical significance of Lapatinib Ditosylate is profound, especially in the treatment of advanced or metastatic breast cancer. Its role in managing HER2 positive breast cancer has been well-established through extensive clinical research. NINGBO INNO PHARMCHEM CO.,LTD. supports this vital area by providing high-quality Lapatinib Ditosylate, ensuring that researchers can conduct precise studies, including the determination of Lapatinib Ditosylate IC50 values, and that pharmaceutical companies have access to reliable material for drug production. Data from various Lapatinib Ditosylate in vivo studies further validate its therapeutic potential.
While Lapatinib Ditosylate has demonstrated significant benefits, ongoing research aims to optimize its use and understand potential Lapatinib Ditosylate side effects to improve patient care. The drug's applicability is also being explored in other types of cancer where EGFR and HER2 pathways play a role. This continuous research is crucial for expanding the therapeutic landscape of targeted cancer therapies.
NINGBO INNO PHARMCHEM CO.,LTD. is committed to advancing oncology by providing the building blocks for innovation. Our supply of high-purity Lapatinib Ditosylate plays a crucial role in supporting researchers and pharmaceutical developers in their quest for more effective cancer treatments. By ensuring the quality and accessibility of essential compounds, we contribute to a future where cancer is more manageable and treatable, reinforcing the importance of compounds like Lapatinib Ditosylate in modern medicine.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
